ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk
Recruiting in Palo Alto (17 mi)
+58 other locations
Overseen ByBinu John
Age: 18+
Sex: Any
Travel: May be covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: Exact Sciences Corporation
No Placebo Group
Trial Summary
What is the purpose of this trial?The primary objective is to assess overall sensitivity and specificity of Oncoguard™ Liver for hepatocellular cancer (HCC) detection in a surveillance population.
Eligibility Criteria
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Ultrasound Surveillance GroupExperimental Treatment3 Interventions
Subjects will undergo standard of care ultrasound surveillance imaging. Subjects with positive ultrasound are anticipated to have standard of care imaging follow-up with CT or MRI as well as other procedures as needed. Subjects with negative ultrasound will be sent for a study CT/MRI.
Group II: CT/MRI Surveillance GroupExperimental Treatment2 Interventions
Subjects will undergo standard of care CT/MRI surveillance imaging.
Find A Clinic Near You
Research locations nearbySelect from list below to view details:
Avicenna Clinical ResearchOak Lawn, IL
NAVREF - Indiana Institute for Medical Research (IIMC)Indianapolis, IN
Great Lakes Medical Research - Susquehanna Research GroupCamp Hill, PA
Xiaoli Ma MdPhiladelphia, PA
More Trial Locations
Loading ...
Who is running the clinical trial?
Exact Sciences CorporationLead Sponsor